Legal Action Initiated: Bragar Eagel & Squire, P.C. Files Class Action Lawsuit against Neogen Corporation, Invites Investors to Consult Firm
Breaking News: Class Action Lawsuit Filed Against Neogen Corporation
In a significant development, the nationally recognized law firm, Bragar Eagel & Squire, P.C., has filed a class action lawsuit against Neogen Corporation. The lawsuit, which was filed in the United States District Court for the Western District of Michigan, alleges violations of securities laws by the company's management.
The complaint, filed in September 2025, alleges that throughout the Class Period, Defendants misrepresented the status of the 3M integration and failed to disclose the negative impact of integration issues on the financial health of Neogen. As a result, investors who purchased or otherwise acquired Neogen shares and suffered a loss are encouraged to contact Bragar Eagel & Squire, P.C. for information regarding these claims.
The lawsuit alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Notably, Neogen had material weaknesses in its internal control over financial reporting as of November 30, 2024.
The lawsuit comes after a series of financial setbacks for Neogen. In April 2025, the company announced that quarterly revenue fell 3.4% to $221 million due to integration issues and again cut its FY25 guidance. This was followed by Neogen revealing that GAAP net income in the second quarter of 2025 was significantly negative due to a $461 million non-cash goodwill impairment charge related to the 3M acquisition. The price of Neogen's common stock fell an additional 17%, to close at $4.96 per share on June 4, 2025.
Moreover, Neogen cut its FY25 revenue and EBITDA guidance on January 10, 2025, and revealed that EBITDA margin is expected to be around the high-teens, representing a considerable drop from the previous quarter's profit margin of 22%.
Investors who believe they may be affected by these allegations are invited to contact Bragar Eagel & Squire, P.C. via email at [email protected], telephone at (212) 355-4648, or by filling out a contact form on their website www.bespc.com. The deadline to apply to be the lead plaintiff in the lawsuit is September 16, 2025.
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.
For updates on this developing story, follow Bragar Eagel & Squire, P.C. on LinkedIn, X, and Facebook. It's important to note that there is no cost or obligation to the investor for contacting Bragar Eagel & Squire, P.C. Brandon Walker and Marion Passmore are the contacts at Bragar Eagel & Squire, P.C. for this matter.
Read also:
- Nightly sweat episodes linked to GERD: Crucial insights explained
- Antitussives: List of Examples, Functions, Adverse Reactions, and Additional Details
- Asthma Diagnosis: Exploring FeNO Tests and Related Treatments
- Unfortunate Financial Disarray for a Family from California After an Expensive Emergency Room Visit with Their Burned Infant